MONOKLONALER INTERLEUKIN-31-ANTIKÖRPER

Patent europeic · EP3653645 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3653645
Numer da la dumonda
EP19196963
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
05-07-2012
Publitgà
20-05-2020
Concedì
21-08-2024
La protecziun finescha il pli tard
04-07-2032
Proxima taxa annuala scadenta
31-07-2027
Classas IPC
C07K 16/24 (2006.01)
G01N 33/53 (2006.01)
Prioritad
US 201161510268 P 21.07.2011
Derivà da
EP17168574
Lingua da l’annunzia
englais
Funtauna
Swissreg

Certificats cumplementars da protecziun

In certificat prolunghescha la protecziun dal patent per in medicament u in product da protecziun da plantas admess en Svizra.

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-08-2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. 01-08-2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. 28-05-2025

    Midada

    Published in Swissreg on 28.05.2025

  4. 28-05-2025

    Midada

    Published in Swissreg on 28.05.2025

  5. 12-09-2024

    Represchentant inscrit

    Representative
    E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 12.09.2024

  6. 21-08-2024

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 21.08.2024

Partidas

Inventur

BAMMERT, Gary F.

Portage, MI 49002, US

DUNHAM, Steven A.

Kalamazoo, MI 49008, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.